Advisory Research’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,829
| Closed | -$305K | – | 460 |
|
|
2021
Q4 | $305K | Sell |
2,829
-2,040
| -42% | -$220K | 0.02% | 283 |
|
|
2021
Q3 | $533K | Hold |
4,869
| – | – | 0.03% | 243 |
|
|
2021
Q2 | $456K | Buy |
4,869
+299
| +7% | +$28K | 0.03% | 273 |
|
|
2021
Q1 | $421K | Buy |
4,570
+678
| +17% | +$62.5K | 0.03% | 278 |
|
|
2020
Q4 | $285K | Sell |
3,892
-197
| -5% | -$14.4K | 0.02% | 295 |
|
|
2020
Q3 | $318K | Sell |
4,089
-1,220
| -23% | -$94.9K | 0.03% | 271 |
|
|
2020
Q2 | $295K | Sell |
5,309
-16,349
| -75% | -$908K | 0.03% | 286 |
|
|
2020
Q1 | $642K | Sell |
21,658
-23,105
| -52% | -$685K | 0.04% | 168 |
|
|
2019
Q4 | $1.62M | Buy |
44,763
+8,170
| +22% | +$296K | 0.07% | 133 |
|
|
2019
Q3 | $996K | Sell |
36,593
-8,070
| -18% | -$220K | 0.05% | 187 |
|
|
2019
Q2 | $1.08M | Buy |
+44,663
| New | +$1.08M | 0.02% | 248 |
|
|
2019
Q1 | – | Sell |
-49,572
| Closed | -$969K | – | 400 |
|
|
2018
Q4 | $969K | Buy |
+49,572
| New | +$969K | 0.02% | 236 |
|